Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Microbial Cell Factories

Fig. 4

From: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model

Fig. 4

Effects of oral administration of LL-TSLP on a DSS-recovery colitis model in mice. Mice were orally dosed with LL-WT or LL-TSLP 5 days prior DSS treatment until the end of study. After DSS treatment mice were allowed to recover for 5 days. Percentage initial weight (a) and DAI (b) were monitored during the DSS-induced colitis phase as well as during the following 5 days of recovery

Back to article page